Skip to main content

Table 3 Organ absorbed doses (mSv/MBq) of [177Lu]Lu-DOTAZOL

From: Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results

OrgansPT1PT2PT3PT4Mean± SD
Adrenals0.0100.0690.0160.0150.0270.028
Brain0.0070.0610.0090.0090.0210.027
Esophagus0.0040.0600.0060.0060.0190.027
Eyes0.0070.0610.0090.0090.0210.027
Gall bladder wall0.0030.0600.0050.0050.0180.028
Left colon0.0050.0620.0070.0070.0200.028
Small intestine0.0040.0610.0060.0060.0190.028
Stomach wall0.0030.0580.0040.0040.0170.027
Right colon0.0030.0600.0050.0050.0180.028
Rectum0.0060.0620.0070.0070.0210.028
Heart wall0.0030.0590.0050.0050.0180.027
Kidneys0.2630.5550.6320.5110.4900.160
Liver0.0030.0590.0050.0050.0180.027
Lungs0.0040.0590.0050.0060.0190.027
Pancreas0.0040.0610.0060.0060.0190.028
Prostate0.0050.0600.0060.0060.0190.027
Salivary glands0.0040.0600.0060.0060.0190.027
Red marrow0.4020.5510.4560.4340.4610.064
Osteogenic cells2.9403.7703.3303.1703.3000.350
Spleen0.0040.0600.0060.0060.0190.027
Testes0.0030.0570.0040.0040.0170.027
Thymus0.0030.0580.0040.0050.0170.027
Thyroid0.0040.0600.0060.0060.0190.027
Urinary bladder wall0.3330.3640.3160.3160.3320.023
Total body0.0690.1420.0810.0770.0920.034